FDA Headquarters Consolidation Initiative - Workplace Enhancement and Management Services
ID: OC-2025-122493_FDA_Headquarters_WEMS-8(a)Sole_Source_AwardType: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Administrative Management and General Management Consulting Services (541611)

PSC

SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT (R408)

Set Aside

8(a) Sole Source (FAR 19.8) (8AN)

Original Source

https://sam.gov/opp/a1db9e61801a41c9a489bdd438afce87/view
Timeline
    Description

    The Department of Health and Human Services, through the Food and Drug Administration (FDA), intends to award an 8(a) sole source contract for Workplace Enhancement and Management Services as part of the FDA Headquarters Consolidation Initiative. The primary objective of this procurement is to enhance space efficiency at the FDA Headquarters in Silver Spring, Maryland, necessitating comprehensive space planning, project management for office renovations, and furniture coordination. This initiative is crucial for optimizing the operational environment to support the FDA's mission of promoting public health, with a total estimated contract value of $4,269,388.87 for a base year and two optional years, starting January 1, 2025. Interested parties may submit qualifications and capabilities by 10:00 AM ET on November 12, 2024, to Andrea Howard at andrea.howard1@fda.hhs.gov or Sandra Bellinger at sandra.bellinger@fda.hhs.gov.

    Point(s) of Contact
    Andrea Howard
    (240) 402-7197
    andrea.howard1@fda.hhs.gov
    Sandra Bellinger
    sandra.bellinger@fda.hhs.gov
    Files
    Title
    Posted
    PWS_30 Oct 2024_DRAFT.docx
    The Performance Work Statement (PWS) outlines the contract requirements for Workplace Enhancement and Management Services at the FDA Headquarters. The objective is to improve space efficiency due to increasing personnel needs, which includes comprehensive space planning, project management for office renovations, and furniture coordination. The contractor must provide five full-time key personnel with specific expertise in architecture, project management, and furniture management, adhering to strict qualifications and responsibilities. The contract encompasses various task areas, including space allocation planning, project development and management, furniture management, and move management. Key personnel are responsible for documentation, project planning, and collaboration with the FDA's Office of Facilities, Engineering and Mission Support (OFEMS) and other stakeholders. The contract is expected to start on January 1, 2025, for a base year with two optional years. Crucially, the government will provide necessary facilities and equipment, while contractors are responsible for maintaining a qualified workforce, implementing quality control measures, and reporting project progress regularly. This initiative underscores the FDA's commitment to optimizing its operational environment in support of its mission to promote public health.
    Similar Opportunities
    Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
    Active
    Health And Human Services, Department Of
    The U.S. Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is conducting market research for a Contractor-Hosted Fully Integrated Records Facility (FIRF) services under an Indefinite Delivery-Indefinite Quantity (IDIQ) contract. The objective is to identify potential small business sources capable of providing comprehensive services such as document processing, data entry, and record tracking, aimed at enhancing the management of records related to public health. This initiative is crucial for improving operational efficiency and ensuring compliance with federal regulations, ultimately supporting the FDA's mission to safeguard public health. Interested vendors must submit their responses, including a completed Vendor Feedback Form and comments on the draft Statement of Work, via email to Contract Specialist Noah Wills by 12:00 PM (Eastern) on November 19, 2024, with the anticipated contract period running from September 15, 2025, to September 14, 2030.
    Business Data Enrichment Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking information on Business Data Enrichment Services to support the establishment of an enterprise master data management program. The primary objective is to enhance the accuracy and completeness of business data across operational and analytical systems, which is crucial for regulatory compliance and public health initiatives. This Request for Information (RFI) is part of the FDA's efforts to gather insights from the marketplace regarding potential solutions and capabilities, particularly in light of legislative requirements such as the Drug Supply Chain and Security Act. Interested stakeholders must submit their responses by November 15, 2024, and can direct inquiries to Noah Padilla at Noah.Padilla@fda.hhs.gov or Peter Lee at peter.lee@fda.hhs.gov.
    PRIMO Software Licensing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for the FY25 Broad Agency Announcement (BAA) aimed at advancing research and development in regulatory science. This initiative seeks to acquire innovative research proposals that enhance the FDA's mission to protect public health by modernizing the evaluation of FDA-regulated products and improving post-market surveillance. Eligible applicants, including private organizations and academic institutions, are encouraged to submit proposals that address critical knowledge gaps and align with FDA priorities, with a submission deadline for full proposals set for February 24, 2025. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Award Notice
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), has announced the FY24 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. This opportunity aims to support innovative research projects that enhance regulatory science, with a focus on health, medical, and biotechnology advancements. The awarded contracts, totaling over $24 million, cover a range of critical topics including drug safety, gene therapy, and methodologies for assessing pediatric opioid exposure, reflecting the federal government's commitment to fostering research initiatives that improve healthcare delivery and regulatory processes. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    Notice of Intent to Limiting sources
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), intends to award a fixed-price contract for Preventative Maintenance and Qualification Services for an Agilent GC/MS and HPLC system. The procurement is limited to Agilent Technologies or its authorized service provider network due to the highly specialized nature of the required services, which include diagnostic tests and the replacement of parts compliant with original equipment manufacturer (OEM) specifications. These services are critical for ensuring the safe and effective operation of the FDA's instruments, as using non-authorized providers could invalidate warranties and pose safety risks. Interested parties capable of meeting these requirements may submit written capability statements by 3:00 p.m. EST on November 12, 2024, to Elena Tatarov at elena.tatarov@fda.hhs.gov.
    Notice of Intent to Sole Source- Investigative Services Police Department (Multiple Locations)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), intends to issue sole source contracts for investigative services with several police departments, including East Providence, North Providence, Virginia, West Virginia, Hopkinton, and Kentucky. The objective of this procurement is to engage these law enforcement agencies for specialized investigative work, with each department receiving an individual contract for a period of performance set for 12 months from the award date. This initiative falls under NAICS code 922120 and is authorized by statute 10 USC 2304 (c)(5), indicating that competitive proposals are not being solicited. Interested firms must submit their capability statements by 10:00 a.m. EST on November 12, 2024, to Nina Montgomery at nina.montgomery@fda.hhs.gov to be considered for this opportunity.
    NTELX Perpetual License, Software Maintenance & Support
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking small business sources to provide a perpetual license, maintenance, and support for NTELX software, specifically for the Office of Regulatory Affairs (ORA). This procurement aims to ensure continuous operational support for mission-critical applications used by ORA staff, which are vital for optimizing import inspections and public health compliance under the Bioterrorism Act of 2002. The NTELX software, including key modules such as PREDICT, FDanalyzer, FDfusion, FDmonitor, and FDauditor, processes approximately 50 million lines of import data annually, making it essential for risk assessment and compliance targeting. Interested small businesses must submit their capability statements by November 14, 2024, and can contact Robert Waite at robert.waite@fda.hhs.gov for further information.
    Preventive Maintenance and Repair Services for a Sciex Triple Quad 5500+ QTRAP HPLC/MS/MS system and Agilent 1260 HPLC system
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified contractors to provide preventive maintenance and repair services for a Sciex Triple Quad 5500+ QTRAP HPLC/MS/MS system and an Agilent 1260 HPLC system. The procurement includes a base year and three optional years of service, requiring one planned maintenance visit annually, prompt on-site corrective maintenance, adherence to OEM specifications, and the provision of software updates and factory-certified replacement parts. These services are critical for maintaining the operational efficiency of analytical equipment used in research at the National Center for Toxicological Research, ensuring that ongoing studies are not delayed. Interested parties should contact Warren Dutter at warren.dutter@fda.hhs.gov or call 870-543-7577 for further details, and the contract will be awarded based on technical capability and experience, with a firm-fixed price structure.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Control (CMC) services related to the development of drug substances under RFP number 75N95024R00094. The primary objective is to secure high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, ensuring compliance with current Good Manufacturing Practices (cGMP) and federal regulations. This initiative is crucial for advancing therapeutic innovations and facilitating collaborations in drug development, with a total funding amount of up to $49.7 million over the contract period from September 1, 2025, to May 14, 2031. Interested parties must submit their proposals by December 3, 2024, and can direct inquiries to primary contact Samson Shifaraw at samson.shifaraw@nih.gov or secondary contact Valerie Whipple at valerie.whipple@nih.gov.